Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2009
11/11/2009EP2114919A2 Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
11/11/2009EP2114918A1 Process for solvent removal from omeprazole salts
11/11/2009EP2114917A2 Pyrrole compounds
11/11/2009EP2114904A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
11/11/2009EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines
11/11/2009EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP2114879A1 Ppar active compounds
11/11/2009EP2114151A1 Isomers of inositol niacinate and uses thereof
11/11/2009EP1943240B1 Chemical process
11/11/2009EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1778673B1 Novel hydantoin derivatives for the treatment of obstructive airway diseases
11/11/2009EP1745021B1 Hydroformylation process for pharmaceutical intermediate
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009EP1492487B1 Mitotic kinesin inhibitors
11/11/2009EP1477186B1 Antipruritics
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
11/11/2009CN101578279A Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
11/11/2009CN101578278A Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
11/11/2009CN101578277A 5-substituted isoindoline compounds
11/11/2009CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/11/2009CN101578265A Sulfonamide derivatives as chymase inhibitors
11/11/2009CN101578261A Heteroaryl-substituted serine amides
11/11/2009CN101578100A Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
11/11/2009CN101575337A Process for extracting matrine or nicotine
11/11/2009CN101575318A Novel dihydropyridine compound and application thereof on preparing drugs for curing and/or preventing virus diseases
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558725C Quinazoline derivatives as antiproliferative agents
11/11/2009CN100558723C Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
11/11/2009CN100558722C A method for the preparation of enantiomerically pure mirtazapine
11/11/2009CN100558715C Protein kinase inhibitors
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/11/2009CN100558355C Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
11/10/2009US7615643 Benzimidazole thiophene compounds
11/10/2009US7615635 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics
11/10/2009US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615557 Such as 1-(2-Chlorophenyl)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)piperidine-4-carboxamide; vanilloid receptor antagonists; urological disorders; inflammation; urinary incontinence; benign prostatic hyperplasia
11/10/2009US7615556 Piperazinyl derivatives as modulators of chemokine receptor activity
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009US7615549 Substituted pyrrolidinones, their manufacture and their use as medicaments
11/10/2009CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases
11/10/2009CA2456093C Process for producing pyridine compound
11/10/2009CA2425422C Stable desloratadine salts, process for their synthesis, and pharmaceutical compositions thereof
11/10/2009CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009WO2009134668A2 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators
11/05/2009WO2009134666A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009WO2009134574A2 Disubstituted phthalazine hedgehog pathway antagonists
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133692A1 Quinoline compound
11/05/2009WO2009133572A2 Process for the preparation of amorphous raberazole sodium
11/05/2009WO2009133556A2 Cisatracurium derivatives, preparation and uses thereof
11/05/2009WO2009133522A1 Piperidine and pyrrolidine compounds
11/05/2009WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009132774A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/05/2009WO2009132739A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009WO2009034433A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275750 Dipeptidyl peptidase inhibitors
11/05/2009US20090275749 Production method of optically active piperazine compound
11/05/2009US20090275748 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
11/05/2009US20090275618 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as cb1 receptor modulators
11/05/2009US20090275617 such as 3-[(1S,3R)-3-fluorocyclopentylamino]methyl-5-(5-fluoro-6-methylpyridin-3-yl)-1-isopropyl-4-methyl-1H-pyrazole, having opioid receptor antagonistic activity, used analgesics or for the treatment of diabetes, neurodegenerative diseases, drug abuse, hypotension, schizophrenia , dementia or obesity
11/05/2009US20090275613 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009US20090275609 Carboxamide Compounds and Methods for Using The Same
11/05/2009US20090275603 NF- kB Inhibitors And Uses Thereof
11/05/2009US20090275599 Therapeutic or prophylactic agent for multiple sclerosis
11/05/2009US20090275591 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitor
11/05/2009US20090275590 (1-azinone)-substituted pyridoindoles
11/05/2009US20090275589 Pyridazine Compound and Use Thereof
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275578 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
11/05/2009US20090275574 Novel compounds-300
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275570 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/05/2009US20090275567 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
11/05/2009US20090275561 Compounds for the Treatment of Hepatitis C
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275555 Substituted indole ligands for the ORL-1 receptor
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009US20090274755 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 1080